Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised
AAdmin
٥ أكتوبر ٢٠٢٦
1 دقيقة قراءة
